Low-dose methoxyflurane provides superior pain relief in trauma patients
Published on 21 July 2022
https://hospitalpharmacyeurope.com/...ides-superior-pain-relief-in-trauma-patients/
Evaluation of the effectiveness and costs of inhaled methoxyflurane versus usual analgesia for prehospital injury and trauma: non-randomised clinical study
Published: 07 July 2022
https://bmcemergmed.biomedcentral.com/articles/10.1186/s12873-022-00664-y
"Results
Overall, 96 trained paramedics and technicians from the East Midlands Ambulance Service NHS Trust (EMAS) prepared 510 doses of methoxyflurane for administration to a total of 483 patients. Comparison data extracted from the EMAS database of UAP episodes involved: 753 patients using Entonox®, 802 patients using intravenous morphine, and 278 patients using intravenous paracetamol. Modelling results included demonstration of faster pain relief with inhaled methoxyflurane (all p-values < 0.001). Methoxyflurane’s time to achieve maximum pain relief was estimated to be significantly shorter: 26.4 min (95%CI 25.0–27.8) versus Entonox® 44.4 min (95%CI 39.5–49.3); 26.5 min (95%CI 25.0–27.9) versus intravenous morphine 41.8 min (95%CI 38.9–44.7); 26.5 min (95%CI 25.1–28.0) versus intravenous paracetamol 40.8 (95%CI 34.7–46.9). Scenario analyses showed that durations spent in severe pain were significantly less for methoxyflurane. Costing scenarios showed the added benefits of methoxyflurane were achieved at higher cost, eg versus Entonox® the additional cost per treated patient was estimated to be £12.30.
Conclusion
When administered to adults with moderate or severe pain due to trauma inhaled methoxyflurane reduced pain more rapidly and to a greater extent than Entonox® and parenteral analgesics. Inclusion of inhaled methoxyflurane to the suite of prehospital analgesics provides a clinically useful addition, but one that is costlier per treated patient."
- Forums
- ASX - By Stock
- Another Positive Study
Low-dose methoxyflurane provides superior pain relief in trauma...
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MVP (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.0¢ |
Change
0.005(1.15%) |
Mkt cap ! $49.56M |
Open | High | Low | Value | Volume |
43.5¢ | 45.0¢ | 43.0¢ | $72.64K | 164.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3355 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 15645 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3355 | 0.440 |
1 | 16033 | 0.430 |
1 | 8000 | 0.420 |
1 | 8964 | 0.410 |
2 | 11372 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 15645 | 1 |
0.460 | 12721 | 4 |
0.465 | 9095 | 1 |
0.470 | 27218 | 3 |
0.475 | 18010 | 1 |
Last trade - 15.56pm 13/09/2024 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online